Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

NCT04322734 is registered in ClinicalTrials.gov with Southwest Autism Research & Resource Center as lead sponsor.

NCT NCT04322734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04322734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
Lead sponsor
Southwest Autism Research & Resource Center
Phase
Observational
Overall status
Recruiting
Start date
December 13, 2023
Completion date
December 31, 2028
Enrollment
500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, brain tumor, epilepsy, mitochondrial diseases, mitochondrial pathology, psychiatric disorder